Biologic antibodies triple discontinuation risk Rheumatology Update The impact antibodies to biologics can have on treatment and patient outcomes has been quantified in a large meta-analysis published in JAMA. The meta-analysis and systematic review involving 59 studies found that patients who developed antibodies to ... |
